Anion exchanger-1 (AE1), an erythroid-specific membrane protein, mediates the Cl À /HCO À 3 exchange across the plasma membrane and regulates intracellular pH. We have found that AE1 was unexpectedly expressed in gastric cancer cells and participated in the tumorigenesis of the cancer. Here, we focus on the induction of AE1 expression and its role in gastric carcinogenesis as well as in the differentiation of K562 cells. The results show that expression of AE1 is not related to genetic mutation or the mRNA level, but rather, that it is modulated by miR-24. miR-24 decreases the expression of AE1 through binding to the 3 0 UTR of AE1 mRNA. Transfection of an miR-24 into gastric cancer cells reduced the elevation of the AE1 protein, which resulted in return of AE1-sequestrated p16 to the nucleus, thereby inhibiting proliferation of the cells. Furthermore, the miR-24 inhibitor cooperated with hemin to induce the expression of AE1 in K562 cells and differentiation of the cells, which is consistent with results obtained from the cells cultured at pH 7.6 or from forced stable expression of AE1. These findings establish a novel regulation of miR-24-related AE1 expression in gastric carcinogenesis and erythropoiesis.
Introduction
The slc4a1 gene belongs to the family of anion exchangers encoding anion exchanger-1 (AE1, also called band-3), an erythroid-specific integral membrane protein (eAE1), which serves the dual roles of Cl À / HCO À 3 exchange and cytoskeletal anchorage to the red cell membrane (Lux et al., 1989) . The gene has been mapped to chromosome 17q21-q22 and consists of 20 exons separated by 19 introns, spanning 17 kb in all (Showe et al., 1987; Sahr et al., 1994; Schofield et al., 1994) . Basal promoter activity of the AE1 gene was detected in erythroid and non-erythroid cells, and expression of AE1 mRNA was identified in various species and tissues (Kudrycki and Shull, 1989; Kudrycki et al., 1990; Richards et al., 1999) . However, the fulllength AE1 protein in mammals is normally restricted to erythroid cells, and the truncated form lacking the N-terminal 69 residues is found in the kidney (kAE1). The N-terminus of eAE1 interacts with many proteins, including ankyrin, protein 4.1 and glycolytic enzymes (Alper et al., 1994) , whereas the N-terminus of kAE1 does not bind to these proteins (Wang et al., 1995) .
Anion exchanger-1 is the major intrinsic protein of the erythrocyte membrane and it was found to be silenced at the protein level in other tissues, suggesting that the protein expression is regulated tightly by mechanisms that have not been elucidated. We have previously shown that full-length AE1, in addition to erythrocytes, is abundantly expressed in the cytoplasm in gastric and colonic adenocarcinoma, with a 56B83% frequency, and gastrointestinal AE1 (gAE1) facilitates the progression of these cancers (Fu et al., 2005; Shen et al., 2007; Xu et al., 2009) . This revealed AE1 to be a protooncogene with an important role in gastric or colonic carcinogenesis if the AE1 mRNA is translated into protein.
In this paper, we first focus attention on the mechanism by which induction of AE1 protein expression is induced in tissues except erythrocytes. Second, we investigate the different roles of AE1 in erythoid and gastric cancer cells. Third, we report an effort to suppress the expression of AE1 and the resulting change in gastric cancer cells.
Results

Identification of three point mutations in the AE1 gene promoter region
To examine, on the basis of the current knowledge of oncogene activation, why a silenced gene in normal tissues was unlocked for protein translation in gastric cancer cells, we investigated the possible factors that might be responsible for the induction mechanism of AE1 translation. The full-length AE1 gene, including the coding sequence and promoter, was cloned and sequenced. As reported by Schofield et al. (1994) , the human AEl cDNA comprises 4756 nts from the ATG codon to the polyadenylation site, and contains an unusually long 3 0 non-coding region of 2020 nts, extending from nt 2737 to 4756. No mutations were found in the coding sequence. However, three point mutations were identified in the promoter region at positions À1722, À702 and À512 in all AE1-positive (SGC7901, MKN45 and AGS), but not in AE1-negative, gastric cancer cells (MKN28) (Figure 1a) . We expected an important role for these mutations in AE1 expression and constructed four vectors containing the wild-type and three mutations (3PM), mutation-1 (M1), mutation-2 (M2) and mutation-3 (M3) sequences, respectively. The relative activity of the wild-type and mutated promoters was compared by using the luciferase reporter gene system. The results indicate that the co-instantaneous three point mutations are not responsible for the abnormal expression of AE1 in gastric cancer cells, and we found a decrease in luciferase activity as compared with that of the wild-type construct ( Figure 1b) . As a single point mutation is not detected in the gastric cancer cells, we therefore consider that the three point mutations are concomitant. The specificity of the three mutations in the AE1 gene promoter in AE1-positive cells implicates the mutations in gAE1 translation. Nevertheless, the relationship between the mutations and AE1 protein expression needs to be further investigated. To clarify whether the mRNA level is associated with the expression of AE1, the AE1 mRNA in seven cell lines was determined by reverse transcription-PCR (RT-PCR), with the AE1 mRNA detectable in all of the cell lines that were investigated in the study. However, the AE1 protein was translated only in the gastric cancer cell line MKN45 and the colonic cancer cell line SW1116 cell. These results indicate that the AE1 mRNA level is not related to AE1 protein expression (Figure 1c) .
The 3
0 UTR of AE1 mRNA is targeted by miR-24 As microRNA (miRNA) has recently been identified as a regulator with a key role in the modulation of target gene expression, one hypothesis might be that miRNAs are involved in the induction mechanism of gAE1 expression. To test the hypothesis, we used common target prediction programs TargetScan and PicTar based on the conserved potential binding sites in the 3 0 -untranslated region (3 0 UTR) of AE1 mRNA. Six potential miRNAs, including miR-133a, miR-133b, miR-296-5p, miR-660, miR-496 and miR-24, were identified. To confirm the informatics prediction, we constructed a luciferase reporter that contained the fulllength 3 0 UTR of AE1 mRNA, with expression driven by the SV40 promoter. The reporter assay showed that only miR-24 was able to significantly repress luciferase activity ( Figure 2a ) and the effect of miR-24 on 
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J Wu et al luciferase activity was dose-dependent ( Figure 2b ). These results indicate that miR-24 specifically targets the AE1 3 0 UTR. The binding sites were predicted to be located at positions 288-294 and 575-581 of the AE1 3 0 UTR, with both sites conserved in various mammals (Figure 2c ). To verify the suppressive effect of miR-24 on AE1 expression through the predicted miR-24-binding sites, two mutant sequences were introduced into the 3 0 -end of the luciferase. Reporter assays demonstrated that both binding sites are necessary for miR-24-mediated repression, suggesting that miR-24 directly targets the two binding sites, especially the 575-581 site in the 3 0 UTR of AE1 mRNA, as a result of which AE1 expression was suppressed (Figure 2d ). miR-24 suppresses the expression of AE1 in gastric cancer cells We have previously shown that gastric cancer cell lines SGC7901 and MKN45, but not MKN28, express the AE1 protein (Shen et al., 2007) . To further investigate whether and how miR-24 modulates AE1 expression, we detected miR-24 expression in SGC7901 and MKN45 cells and compared it with the expression in MKN28 cells. The results showed that two AE1-positive gastric cancer cell lines have a lower miR-24 expression level as compared with that in the AE1-negative MKN28 cell line (Figure 3a) . The results concerning the relationship between AE1 and miR-24 support that the AE1 is an miR-24 target gene. In addition, we examined the effects of miR-24 on the AE1 mRNA ( Figure 3b ) and protein ( Figure 3c ) in MKN45 cells. The results show that miR-24 at 150 pmol led to significant decrease in the level of the endogenous AE1 protein, but AE1 mRNA was not affected. In contrast, an miR-24 inhibitor at 150 pmol significantly upregulated the endogenous AE1 protein level compared with that in control or non-specific scramble transfection (Figure 3d ). These results strongly suggest that miR-24 modulates the translation process of the AE1 protein, but not the transcription or stability of AE1 mRNA.
We previously reported that gAE1 interacts with p16 and sequestrates the protein in the cytoplasm in gastric and colonic adenocarcinoma. Small interference 0 UTR luciferase reporters with wild-type or mutated target sites, along with NSC or miR-24 mimics. Luciferase assay was performed 48 h after transfection. The data represent the mean ± s.d. of three independent experiments. The asterisk indicates a significant difference compared with wild-type construct cells (Po0.05). AE1, anion exchanger-1; miRNA, microRNA; miR-24, miRNA 24; NSC, non-specific control; UTR, untranslated region.
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RNA-mediated knockdown of AE1 resulted in the return of p16 to the nucleus (Shen et al., 2007) . To explore whether miR-24 would interfere with AE1 signaling, p16 translocation from the cytoplasm to the nucleus was detected in AE1-positive MKN45 and SGC7901 cells. As shown in Figure 4 , expression of miR-24 led to return of p16 to the nucleus in both cancer cell lines. Taken together, these results suggest that miR-24 specifically interferes with AE1/p16 signaling by targeting the 3 0 UTR of AE1 mRNA and reducing AE1 expression.
miR-24 inhibits proliferation
Our previous work demonstrated the expression of gAE1 to be associated with deeper invasion, increased tumor size and lower 5-year survival rate among gastric cancer patients (Xu et al., 2009) . To determine whether miR-24-mediated AE1 reduction affects the cell-cycle regulation and/or movement of gastric cancer cells, MKN45 and SGC7901 cells were transfected with miR-24 (150 pmol) for 48 h to reduce AE1 expression. Cell-cycle analysis of intact cells revealed an miR-24 mimic-induced arrest at the G 2 /M phase in both the cell lines (Figures 5a and b) . Furthermore, we performed migration investigation using wound-scratch migration assays to quantitatively evaluate the effects on the movement of the cancer cells. The miR-24 mimics do not inhibit, but rather enhance the cell migration of the two gastric cancer cell lines (Figures 5c and d) , suggesting that the AE1-related malignancy is mainly dependent on the enhanced proliferation of the gastric cancer cells.
Functional AE1 promote the differentiation of K562 cells Functional AE1 is an erythoid-specific membrane protein abundantly expressed on the surface of mature erythrocyte. AE1 mRNA was detected in the K562 cells (Figure 1c ), but it was not translated to protein, suggesting that absence of AE1 protein might be involved in the arrest of differentiation of K562 cells. To test this, K562 cells were treated with different factors, in an effort to induce AE1 expression, as follows ( Figure 6a ): first, a pQCXIN-AE1 plasmid was stably transfected into K562 cells to maintain stable expression of AE1. Second, the K562 cells were cultured in medium adjusted for different pH values ranging from 7.35 to 8.0. AE1 was expressed while the pH was between 7.45 and 7.8, and expression was maximal at pH 7.6. Third, an miR-24 inhibitor was transfected into the K562 cells alone or together with hemin, an inducer of erythroid differentiation, for 48 h. The miR-24 inhibitor or hemin alone did not induce the expression of AE1 in K562 cells, but cooperatively they induced the expression of AE1. With the exception of gAE1, which failed to traffic to the plasma membrane and was accumulated in the cytoplasm of gastric cancer cells (Shen et al., 2007) , the AE1 in K562 cells did successfully traffic to the plasma membrane (Figure 6b ), suggesting that the AE1 is a functional protein. The differentiation of the K562 cells treated with the three factors was assessed by benzidine staining, which was used to detect the presence of hemoglobin and erythoid differentiation (Figure 6c) . The results show that the differentiation of K562 cells is strongly pH-dependent and the pH of 7.6 to be the most potent factor for the induction of AE1 expression and erythoid differentiation, and that functional AE1 might play its role by regulating intra-and extra-cellular pH. DIDS (4,4 0 -diisothiocyanato-stilbene-2,2 0 -disulfonic acid), a known inhibitor of AE1 anion exchange, significantly blocked the differentiation of K562 cells, which was induced by AE1, the higher culture medium pH 
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Discussion
In this study, we provide evidence that AE1 mRNA is detectable in several types of cancer and HEK293 cells, whereas AE1 protein was not detected in most cells investigated in this study. The results are consistent with the distribution of AE1 protein in normal tissues. AE1 mRNA, which is translated into protein in gastric and colonic cancer cells, revealed abnormal induction of the translation process. Here we show for the first time that miR-24 is a key factor for the induction of AE1 translation in gastric cancer cells. miR-24 downregulates the expression of AE1 by targeting the 3 0 UTR of its Induction of AE1 and its roles in cancer cells J Wu et al mRNA, which inhibits the proliferation of gastric cancer cells.
As reported recently, miRNAs are abundant, small non-coding RNAs that mediate sequence-specific, posttranscriptional gene expression by binding to the target 3 0 UTR of mRNA, and have been implicated in the regulation of certain cancer-related processes, including development, differentiation, apoptosis and proliferation (Merkerova et al., 2008; Ruan et al., 2009; Yang et al., 2009) . To date, miR-24 has been implicated in the regulation of hematopoietic differentiation and cell proliferation (Lal et al., 2008 (Lal et al., , 2009 Wang et al., 2008) . For example, miR-24 downregulates the expression of human dihydrofolate reductase and expression of miR-24 is upregulated during differentiation of human leukemia cells. Recent studies have indicated that the miR-24 inhibits the differentiation of K562 cells. It is noteworthy that in normal erythroid lineage cells, miR-24 was downregulated along with progression of erythroid differentiation (Georgantas et al., 2007) . In contrast, AE1 protein was expressed in only a minority of erythroid progenitors (BFU-E and CFU-E), but was strongly positive in normoblasts and reached its peak at the terminal differentiation erythroid cells (Lehnert and Lodish, 1988; McAdams et al., 1998) . The negative relationship between miR-24 level and AE1 expression suggests that retreat of miR-24 may be a signal for expression of AE1 in differentiated erythroid cells. Functional AE1 mediates the Cl À /HCO 3 À exchange across the plasma membrane, and so pH change could impact the differentiation of erythoid lineage cells. The importance of functional AE1 in the regulation of differentiated erythroid cells is supported by the funding that pH is a potent modulator and plays a role in the maintenance of the bone marrow microenvironment and development of erythroid cells (Endo et al., 1994; McAdams et al., 1997) .
Due to universal silencing of AE1 in tissues, miR-24 may be a general regulator for AE1 translation during individual development. It is considered that miR-24 was downregulated along with differentiation of erythroid lineages; thus the suppressive effect on AE1 expression was removed and AE1 was largely expressed in the late stage of erythroid cells. Functional AE1 further boosted the differentiation process through AE1-mediated exchange of Cl À /HCO 3 À . In contrast, in other solid cells, miR-24 may maintain a level, which suppresses AE1 translation, and so AE1 is silenced in all This is the first report that miR-24 is involved in the exceptional expression of AE1 in gastric cancer cells. Our previous studies showed that gAE1 was expressed in the cytoplasm of both gastric cancer cell lines and primary gastric cancer tissue. AE1 interacts with the Differentiation of K562 cells treated with various factors was detected by benzidine staining. The symbols represent significant difference. m, compared with the empty vector; mm, compared with the control; %, compared with NSC-miR-24i; %%, compared with the control; , compared with hemin þ NSC-miR-24i. (d) A 100-mM concentration of DIDS significantly blocked the differentiation of K562 cells, which was induced by AE1 expression, higher pH of 7.6 and miR-24i transfection. The symbols represent significant difference. m, compared with AE1 transfection; mm, compared with pH 7.6; %, compared with miR-24i; %%, compared with hemin þ miR-24i. AE1, anion exchanger-1; DIDS, 4,4 0 -diisothiocyanato-stilbene-2,2 0 -disulfonic acid; miRNA, microRNA; miR-24, miRNA 24; NSC, non-specific control; RT-PCR, reverse transcription-PCR; UTR, untranslated region.
Induction of AE1 and its roles in cancer cells J Wu et al tumor suppressor p16 and sequesters it in the cytoplasm, which leads to loss of control of cell-cycle regulation and induction of gastric carcinogenesis. The AE1 protein also affected other cell proliferation-signaling pathways in gastric cancer cells (data not shown). Transfection of miR-24 to MKN45 or SGC7901 cells resulted in the return of p16 to the nucleus, which is consistent with the consequence of small interference RNA-mediated knockdown of AE1 (Fu et al., 2005; Shen et al., 2007) , confirming miR-24-regulated downregulation of AE1. The p16 gene products are thought to negatively control the progression of eukaryotic cells through the G 1 arrest of the cell cycle (Shapiro et al., 2000) . The present result demonstrated that miR-24 induced cell-cycle arrest in the G 2 phase. The contribution of nuclear p16 to the G 2 phase arrest is unclear, but studies using in vitro cultured cells have previously demonstrated that p16 inhibits cdk4/cyclin-D activity in the late S/early G 2 phase, which apparently is required for G 2 phase progression. Alternatively, p16 may have a role in constituting a G 1 phase arrest after G 2 arrest (Gabrielli et al., 1999; Pavey et al., 2001) .
The erythrocyte AE1 interacts with protein 4.1, ankyrin and spectrin, which comprise the erythrocyte cytoskeleton, and the importance of the interactions in the shape maintenance and deformability of erythrocytes is well-established (Walensky et al., 1998; Galluzzi et al., 2001; An et al., 2005) . Recent studies have indicated that the cytoskeleton in nucleated cells provides mechanical support to the cell plasma membrane, and cytoskeletal networks are present in various intracellular structures that are involved in the regulation of major cellular functions, such as morphogenesis, cell proliferation, cell migration and cell-cell contact (Gascard and Mohandas, 2000; Takakuwa, 2000; Durham and Herman, 2009 ). miR-24-mediated downregulation of AE1 in gastric cancer cells resulted in a more rapid migration of the cells, suggesting that expression of AE1 is inconducive to the organization of the cytoskeleton and movement of the cancer cells. Eventually, this does not defeat the AE1-induced proliferation of the gastric cancer cells and the expression of AE1 represents deeper invasion and lower 5-year survival.
K562 cells are bipotent cells, which can be induced to express erythroid or megakaryocytic properties depending on the inducers. Therefore, differentiation of K562 cells has served as a representative model of studies of erythroid differentiation for many years (Huo et al., 2006; Wang et al., 2009) . The undetectable expression of AE1 in K562 cells suggests that miR-24 may take part in the tumorigenesis of erythroleukemia by arresting erythroid maturation through silencing of AE1 expression. The functional AE1-induced differentiation of K562 cells may depend mainly on its role in the regulation of the pH. Our results are consistent with the data reported by Endo et al. Their experiments indicated that a significantly greater proportion of cells acquire a mature erythroid phenotype when cultured at pH 7.6 than when cultured at lower pH (Endo et al., 1994) . The distribution of erythroid cell types was more immature at a low pH and more mature at a higher pH.
The results raise the important question of why AE1 promotes the differentiation of K562 cells, but malignancy in gastric cancer cells. The determinant is that the AE1 in the normal erythroid lineage or K562 cells was expressed on the cell surface, which means that the functional AE1 was expressed. However, gAE1 cannot traffic to the plasma membrane and remained in the cytoplasm. The cytoplasmic gAE1 interacts with the tumor suppressor p16 and sequesters it in the cytoplasm, thus affecting cell-cycle regulation. gAE1 is thus not a functional form of AE1, but rather, a carcinogenic factor.
This study not only establishes the novel connection between miR-24 and AE1, but also demonstrates that locking and induction of AE1 expression in erythoid and gastric cancer cells plays different roles in the differentiation of erythoid cells and tumorigenesis of gastric cancer cells, respectively. miR-24 is likely to predominantly operate by inhibiting translation. In addition, alkalization of the environment around the gastric epithelium may also take part in the induction of AE1 expression (Friis-Hansen, 2006) . These data provide new insights into the molecular mechanisms of human erythropoiesis and gastric tumorigenesis.
Materials and methods
Cell culture and reagents
The human erythroleukemia cell line K562, gastric cancer cell lines MKN45, SGC7901, the colon carcinoma cell line SW1116, the embryonic kidney cell line HEK293, the pancreatic cancer cell line Patu8988 and the hepatocellular liver carcinoma cell line HepG2 were purchased from the Cell Bank of Shanghai Institutes for Biological Science (Shanghai, China) and cultured in RPMI-1640/Dulbecco's Modified Eagles' medium (Hyclone, Logan, UT, USA) supplemented with 10% fetal calf serum (Hyclone), at 37 1C and under 5% CO 2 , and passed every 2-3 days to maintain logarithmic growth. The miRNA mimics and inhibitors were provided by Shanghai Genepharma (Shanghai, China). The AE1 inhibitor DIDS was purchased from Sigma Chemical (St Louis, MO, USA).
Isolation and sequencing of AE1 mRNA
The cell lines MKN45, SW1116, HEK293, Patu8988, HepG2 and K562 were cultured normally for 48 h and total RNA from cells was extracted using the Trizol reagent (TaKaRa Biotechnology, Dalian, China). AE1 cDNA was amplified by using the One-step RT-PCR kit according to the manufacturer's protocol (TaKaRa Biotechnology). The primers of AE1 were as follows: forward (930), 5 0 -TGGCTGTACTGTTTGG CATC-3 0 ; reverse (1914), 5 0 -AGTGAGGATGAGGACGAA GG-3 0 Construction of AE1 reporter plasmids and luciferase assay To sequence the human AE1 gene 5 0 flanking region, human genomic DNA was extracted from MKN45, SGC-7901, HepG2 and Patu-8988 cell lines. A 1.9-kb fragment representing the 5 0 flanking region of the human AE1 gene was amplified by RT-PCR (from À1898 to À1 relative to ATG). The PCR products were purified through a spin column (Qiagen, Valencia, CA, USA) and directly by cycle sequencing (Applied Biosystems, CA, USA). The PCR products were ligated into a pGL3-Basic vector (Promega, Mannheim, Germany) containing the firefly luciferase gene as a reporter. For cloning of the AE1 3 0 UTR, the 3 0 UTR region (787 bp) was amplified and inserted into an XbaI site located between the luciferase coding sequence and the poly(A) signal downstream from the firefly luciferase gene, in the pGL3-control vector. All constructs used in this study were restriction-mapped and sequenced to confirm their authenticity.
Luciferase assay SGC7901 or MKN45 cells were transfected with the indicated constructs, miRNA mimics or inhibitors (600 ng) together with the internal control pRenilla-TK vector (60 ng). Forty-eight hours after transfection, the cells were harvested for luciferase assay. Each experiment was performed in triplicate and the data represent the mean±standard deviation (s.d.) of three independent experiments after normalization to Renilla reniformis activity.
Western blotting
For western blotting analysis of AE1, cells were harvested and washed twice with ice-cold phosphate-buffered saline (PBS) and lysed with ice-cold lysis buffer (0.1 M Tris (pH 6.8), 4% sodium dodecyl sulfate, 20% glycerol and 0.2 M dithiothreitol). The protein samples were equally loaded on 10B12% sodium dodecyl sulfate-polyacrylamide gel and electrophoretically transferred to nitrocellulose membranes at 100 volts. The membranes were blocked with 5% non-fat milk in Trisbuffered saline containing 0.1% Tween-20 and incubated with each primary antibody overnight at 4 1C. The primary anti-AE1 antibodies used in this study were from Santa Cruz Biotechnology (Santa cruz, CA, USA). Finally, blots were incubated with horseradish peroxidase-linked rabbit antimouse secondary antibody (Sigma, St Louis, MO, USA). Detection was performed using a chemiluminescence phototope-horseradish peroxidase kit according to the manufacturer's instructions (Pierce, Rockford, IL, USA).
Real-time PCR
The MKN45, MKN28 and SGC7901 cells were cultured in Dulbecco's Modified Eagles' medium. miR-24 levels were detected by real-time quantitative PCR using the Applied Biosystems 7500 Fast Real-Time PCR System. The sequences of primers, which were designed for miR-24 and U6 (for normalization), to analyze their expression, were as follows: miR-24 stem-loop primer, 5 0 -GTCGTATCCAGTGCAGGG TCCGAGGTATTCGCACTGGATACGACCTGTTC-3 0 ; miR-24 forward, 5 0 -GCAGATGGCTCAGTTCAGCAG-3 0 ; miR-24 reverse, 5 0 -GTGCAGGGTCCGAGGT-3 0 ; U6 forward, 5 0 -CTC GCTTCGGCAGCACA-3 0 ; and U6 reverse transcript and reverse, 5 0 -AACGCTTCACGAATTTGCGT-3 0 . The data are expressed by the 2 ÀDDCt method.
Stable expression of AE1 in K562 cells
The pQCXIN retroviral vector (Clontech, Palo Alto, CA, USA) containing the human AE1 cDNA was constructed and identified. The pQCXIN-AE1 plasmid was then transfected into the HEK 293T cells, along with retroviral vector VSV-G and Gag-Pol plasmids. Transfection was performed by using FuGENE HD (Roche, Mannheim, Germany), according to the manufacturer's instructions. K562 cells were treated with the supernatant containing the reconstructed retrovirus obtained from HEK 293T cells. After transduction for 48 h, K562 cells stably overexpressing the AE1 were selected with 800 ng/ml G418 for 2 weeks.
pH-adjusted cell cultures
The pH of RPMI-1640 was measured by transferring the contents of the medium into 50-ml centrifuge tubes and calibrating to specific value on ph/Ion 510. Mediums with different pH were filtered using Millex GP (0.22 mm) before cell culturing.
Cell-cycle analysis using flow cytometry MKN45 and SGC7901 cells were seeded onto six-well plates and transfected with nonspecific control (NSC) and miR-24 (75 nM), respectively. The cells were harvested at 2 days after transfection and fixed with 75% ethanol at À20 1C overnight. All samples were analyzed by flow cytometry.
Immunofluorescence MKN45, SGC7901 and K562 cells were seeded onto coverslips in six-well plates and cultured overnight. Cells were washed with PBS three times and then fixed with 4% paraformaldehyde for 15 min before treating with 0.3% Triton X-100 at room temperature. After that, 3% bovine serum albumin was used to block non-specific binding at room temperature for 1 h and the cells were incubated with primary anti-p16 or anti-AE1 antibodies overnight at 4 1C respectively. Then cells were washed with PBS three times every 5 min and incubated for 1 h with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG. After washing with PBS three times, the cells were treated with 1 mM 4 0 ,6 0 -diamidino-2-phenylindole dihydrochloride (DAPI) for 5 min. The samples were mounted for imaging using a Radiance 2100 Laser Scanning System (Bio-Rad, Hertfordshire, UK).
Cell fractionation
The process of cell fractionation has been described in our previous paper (Shen et al., 2007) . Briefly, cells were incubated in lysis buffer for 10 min, and then supplemented with NP-40 and cocktail (Sigma) for 1 min on ice. The lysates were centrifuged for 1 min at 2300 g. The supernatants contained cytoplasmic protein extracts. The pellets were washed and resuspended in extraction buffer and incubated for 20 min on ice. Then, samples were centrifuged at 12 000 g for 10 min and the supernatants were collected as nuclear protein extracts.
Benzidine staining K562 cells were stably transfected with AE1 constructs, transiently transfected with miR-24 inhibitor or cultured under conditions of differing pH. The cells were harvested, washed twice with PBS and stained with benzidine solution containing 0.2% benzidine-glacial acetic acid and 30% H 2 O 2 (benzidine and glacial acetic acid solution:H 2 O 2 ¼ 25:1). Deep brownblue-colored cells were counted as positive. Each treatment was performed in triplicate wells and the experiment was repeated for three times.
Wound assays Scratch-wounding assays were performed using MKN45 and SGC7901 cells, which were transfected with NSC and miR-24, respectively. After transfection for 6 h, the cells were cultured in serum-free medium for 24 h and then a single linear wound was made using a 20-ml pipette tip. The cells were washed gently with PBS to remove cellular debris before transferring to fresh Dulbecco's Modified Eagles' medium supplemented with 0.1% fetal bovine serum to block cell proliferation, and then were incubated at 37 1C under a 5% CO 2 atmosphere for 12 and 24 h. The Cells were photographed using a microscope (Nikon, Japan) at Â 20 magnification and the wound areas were measured. Wound area at each time point was measured using the ImagePro Plus software. Wound closure was expressed as the percentage of the original wound area±s.d. Significance was determined using by one-way analysis of variance.
